ArticleCureus2026
Ghost Melanoma: Endobronchial Melanoma of Unknown Primary Mimicking Primary Lung Cancer.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma of unknown primary (MUP) with endobronchial involvement is a rare diagnostic presentation that may clinically and radiologically mimic primary lung cancer. We report the case of a 46-year-old man, a chronic smoker with a 20-pack-year history and a previous excisional biopsy of an atypical scalp nevus, who presented with low-volume hemoptysis and constitutional decline evolving over three months. Chest imaging revealed a large necrotic mass involving the right middle and lower lobes, associated with bilateral pulmonary nodules in a cannonball pattern and mediastinal lymphadenopathy, initially suggesting an advanced primary lung malignancy. Bronchoscopy demonstrated an obstructing endobronchial lesion at the level of the bronchus intermedius. Histopathological examination revealed a malignant melanocytic proliferation, with immunohistochemistry showing positivity for melanoma antigen recognized by T cells 1 (Melan-A) and human melanoma black 45 (HMB-45) and negativity for thyroid transcription factor-1 (TTF-1), cytokeratin AE1/AE3 (AE1/AE3), and p40, supporting the diagnosis of malignant melanoma. Extensive evaluation for an extrathoracic primary, including complete dermatological and mucosal examination and fundoscopy, failed to identify a primary lesion. Staging revealed additional brain, peritoneal, and bone involvement at diagnosis. Primary pulmonary melanoma and MUP with endobronchial involvement were considered, with the overall clinical and pathological findings favoring the latter diagnosis. The case was discussed at a multidisciplinary tumor board, and systemic immunotherapy was initiated. This case highlights the diagnostic challenge posed by an endobronchial melanocytic lesion in a patient with a smoking history and emphasizes the importance of a thorough search for an extrathoracic primary before diagnosing primary pulmonary melanoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.